1 earning revenue on a royalty deal the CEO got screwed on, APAS seeking FDA approval but still under development with Hettich, and the other is a pipe dream (w/ huge potential as does APAS) that may take years to come into fruition.That's why.
LBT has a great technology and we'll really see it moving when it gets FDA approval and then a distribution deal. This is a long term, not short term buy.
- Forums
- ASX - Short Term Trading
- Short Term trading Week Starting: 24th Nov
1 earning revenue on a royalty deal the CEO got screwed on, APAS...
-
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Exciting new copper-gold discoveries at Tarraji-Yampi: Dive into the strong drilling results now